Literature DB >> 15508429

Substrates of human cytochromes P450 from families CYP1 and CYP2: analysis of enzyme selectivity and metabolism.

David F V Lewis1, Brian G Lake, Maurice Dickins.   

Abstract

A compilation of information relating to substrate metabolism via human cytochromes P450 (CYP) from the CYP1 and CYP2 families is reported. The data presented include details of preferred sites of metabolism and Km values (usually for the expressed enzymes) for each reaction for selected substrates of CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 and CYP2E1. Although other P450 databases are available, they do not provide such information as is collated here, and which can prove useful for comparing P450 substrate characteristics. This information can be employed in analysing the structural requirements for human P450 enzyme selectivity and for establishing various rules regarding preferred site of metabolism for selective P450 substrates. For example, in most cases it would appear that there is a set number of intervening 'heavy' atoms (atoms other than hydrogen) between sites of metabolism and key hydrogen bond acceptors (or donors) for human P450 substrates, with the number of intervening atoms being dependent upon the type of P450 involved.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15508429     DOI: 10.1515/dmdi.2004.20.3.111

Source DB:  PubMed          Journal:  Drug Metabol Drug Interact        ISSN: 0792-5077


  6 in total

1.  Liver-specific cytochrome P450 CYP2C22 is a direct target of retinoic acid and a retinoic acid-metabolizing enzyme in rat liver.

Authors:  Linxi Qian; Reza Zolfaghari; A Catharine Ross
Journal:  J Lipid Res       Date:  2010-02-10       Impact factor: 5.922

2.  The chemical defensome: environmental sensing and response genes in the Strongylocentrotus purpuratus genome.

Authors:  J V Goldstone; A Hamdoun; B J Cole; M Howard-Ashby; D W Nebert; M Scally; M Dean; D Epel; M E Hahn; J J Stegeman
Journal:  Dev Biol       Date:  2006-09-03       Impact factor: 3.582

3.  Decreased susceptibility of the cytochrome P450 2B6 variant K262R to inhibition by several clinically important drugs.

Authors:  Jyothi C Talakad; Santosh Kumar; James R Halpert
Journal:  Drug Metab Dispos       Date:  2008-12-12       Impact factor: 3.922

Review 4.  Environmental sensing and response genes in cnidaria: the chemical defensome in the sea anemone Nematostella vectensis.

Authors:  J V Goldstone
Journal:  Cell Biol Toxicol       Date:  2008-10-28       Impact factor: 6.691

5.  Pharmacogenetics of analgesic drugs.

Authors:  Roman Cregg; Giovanna Russo; Anthony Gubbay; Ruth Branford; Hiroe Sato
Journal:  Br J Pain       Date:  2013-11

6.  Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance.

Authors:  Ulrich M Zanger; Kathrin Klein
Journal:  Front Genet       Date:  2013-03-05       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.